Skip to main content
Top

07-05-2024 | Respiratory Microbiota | Original Contribution

Effect of prebiotic fiber on physical function and gut microbiota in adults, mostly women, with knee osteoarthritis and obesity: a randomized controlled trial

Authors: Rafael Fortuna, Weilan Wang, Shyamchand Mayengbam, Erin W. Noye Tuplin, Kara Sampsell, Keith A. Sharkey, David A. Hart, Raylene A. Reimer

Published in: European Journal of Nutrition

Login to get access

Abstract

Purpose

Obesity is a primary risk factor for knee osteoarthritis (OA). Prebiotics enhance beneficial gut microbes and can reduce body fat and inflammation. Our objective was to examine if a 6-month prebiotic intervention improved physical function in adults with knee osteoarthritis and obesity. We also measured knee pain, body composition, quality of life, gut microbiota, inflammatory markers, and serum metabolomics.

Methods

Adults (n = 54, mostly women) with co-morbid obesity (BMI > 30 kg/m2) and unilateral/bilateral knee OA were randomly assigned to prebiotic (oligofructose-enriched inulin; 16 g/day; n = 31) or isocaloric placebo (maltodextrin; n = 21) for 6 months. Performance based-tests, knee pain, quality of life, serum metabolomics and inflammatory markers, and fecal microbiota and short-chain fatty acids were assessed.

Results

Significant between group differences were detected for the change in timed-up-and-go test, 40 m fast paced walk test, and hand grip strength test from baseline that favored prebiotic over placebo. Prebiotic also reduced trunk fat mass (kg) at 6 months and trunk fat (%) at 3 months compared to placebo. There was a trend (p = 0.059) for reduced knee pain at 6 months with prebiotic versus placebo. In gut microbiota analysis, a total of 37 amplicon sequence variants differed between groups. Bifidobacterium abundance was positively correlated with distance walked in the 6-min walk test and hand grip strength. At 6 months, there was a significant separation of serum metabolites between groups with upregulation of phenylalanine and tyrosine metabolism with prebiotic.

Conclusion

Prebiotics may hold promise for conservative management of knee osteoarthritis in adults with obesity and larger trials are warranted.

Clinical Trial Registration

Clinicaltrials.gov/study/NCT04172688.
Appendix
Available only for authorised users
Literature
2.
go back to reference Cleveland RJ, Nelson AE, Callahan L (2019) Knee and hip osteoarthritis as predictors of premature death: a review of the evidence. Clin Exp Rheumatol 37(Suppl 1):24–30PubMedPubMedCentral Cleveland RJ, Nelson AE, Callahan L (2019) Knee and hip osteoarthritis as predictors of premature death: a review of the evidence. Clin Exp Rheumatol 37(Suppl 1):24–30PubMedPubMedCentral
4.
go back to reference Yedlin E, Cisternas M (2018) United States bone and joint initiative: the burden of musculoskeletal diseases in the United States (BMUS), Fourth edition, Forthcoming Rosemont, IL Yedlin E, Cisternas M (2018) United States bone and joint initiative: the burden of musculoskeletal diseases in the United States (BMUS), Fourth edition, Forthcoming Rosemont, IL
6.
Metadata
Title
Effect of prebiotic fiber on physical function and gut microbiota in adults, mostly women, with knee osteoarthritis and obesity: a randomized controlled trial
Authors
Rafael Fortuna
Weilan Wang
Shyamchand Mayengbam
Erin W. Noye Tuplin
Kara Sampsell
Keith A. Sharkey
David A. Hart
Raylene A. Reimer
Publication date
07-05-2024
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Nutrition
Print ISSN: 1436-6207
Electronic ISSN: 1436-6215
DOI
https://doi.org/10.1007/s00394-024-03415-w
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.